Abstract:Abstract Background Clear cell renal cell carcinoma (ccRCC) is one of the most lethal urological malignancies, but the pathogenesis and prognosis of ccRCC remain obscure, which need to be better understand. Methods Differentially expressed genes were identified and function enrichment analyses were performed using three publicly available ccRCC gene expression profiles downloaded from the Gene Expression Omnibus database. The protein-protein interaction and the competing endogenous RNA (ceRNA) networks were visualized by Cytoscape. Multivariate Cox analysis was used to predict an optimal risk mode, and the survival analysis was performed with the Kaplan-Meier curve and log-rank test. Protein expression data were downloaded from Clinical Proteomic Tumor Analysis Consortium database and Human Protein Atlas database, and the clinical information as well as the corresponding lncRNA and miRNA expression data were obtained via The Cancer Genome Atlas database. The co-expressed genes and potential function of candidate genes were explored using data exacted from the Cancer Cell Line Encyclopedia database. Results Of the 1044 differentially expressed genes shared across the three datasets, 461 were upregulated, and 583 were downregulated, which significantly enriched in multiple immunoregulatory-related biological process and tumor-associated pathways, such as HIF-1, PI3K-AKT, P53 and Rap1 signaling pathways. In the most significant module, 36 hub genes were identified and were predominantly enriched in inflammatory response and immune and biotic stimulus pathways. Survival analysis and validation of the hub genes at the mRNA and protein expression levels suggested that these genes, particularly complement component 3 (C3) and fibronectin 1 (FN1), were primarily responsible for ccRCC tumorigenesis and progression. Increased expression of C3 or FN1 was also associated with advanced clinical stage, high pathological grade, and poor survival in patients with ccRCC. Univariate and multivariate Cox regression analysis qualified the expression levels of the two genes as candidate biomarkers for predicting poor survival. FN1 was potentially regulated by miR-429, miR-216b and miR-217, and constructed a bridge to C3 and C3AR1 in the ceRNA network, indicating a critical position of FN1. Conclusions The biomarkers C3 and FN1 could provide theoretical support for the development of a novel prognostic tool to advance ccRCC diagnosis and targeted therapy.

Identification of angiogenesis-related miRNAs in a population of patients with renal clear cell carcinoma.

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach

Differential Expression Profile of Micrornas in Clear Cell Renal Cell Carcinoma

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key Mirnas

Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis

Integrated Profiling of Micrornas and Mrnas: Micrornas Located on Xq27.3 Associate with Clear Cell Renal Cell Carcinoma.

Identification of Mir-130B As an Oncogene in Renal Cell Carcinoma

Differential microRNA expression in renal cell carcinoma.

Elevated Microrna-185 is Associated with High Vascular Endothelial Growth Factor Receptor 2 Expression Levels and High Microvessel Density in Clear Cell Renal Cell Carcinoma

New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies

The miR-200 family as prognostic markers in clear cell renal cell carcinoma.

Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma

Identification of Mir-18A-5p As an Oncogene and Prognostic Biomarker in RCC

Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.

Identification of Mir-30B As an Oncogene in Renal Cell Carcinoma

Construction and Comprehensive Analysis of Dysregulated Long Non-Coding RNA-associated Competing Endogenous RNA Network in Clear Cell Renal Cell Carcinoma

Identification of Potential Novel Differentially-Expressed Genes and Their Role in Invasion and Migration in Renal Cell Carcinoma.

MiR-1 Downregulation Correlates with Poor Survival in Clear Cell Renal Cell Carcinoma Where It Interferes with Cell Cycle Regulation and Metastasis.

Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma

Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.

The Expression and Clinical Significance of Microrna-130B-5p,a Novel Biomarker in Renal Cancer